aromatase inhibition

DRUG4 trials

Sponsors

Intarcia Therapeutics, Robert H. Lurie Cancer Center, University Hospital, Ghent

Conditions

Breast NeoplasmsHealthyNeoplasms, Hormone-DependentNeoplasms, Hormone-dependentStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer

Phase 1

Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men

CompletedNCT00740194

University Hospital, GhentHealthy

Start: 2008-08-31End: 2010-08-31Target: 20Updated: 2011-08-30

Phase 2

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

WithdrawnNCT00080613

Robert H. Lurie Cancer CenterStage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer +1

Updated: 2013-07-10

Phase 3

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

CompletedNCT00044291

Intarcia TherapeuticsBreast Neoplasms, Neoplasms, Hormone-dependent

Start: 2002-06-30End: 2006-01-31Updated: 2015-07-31

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

TerminatedNCT00097344

Intarcia TherapeuticsBreast Neoplasms, Neoplasms, Hormone-Dependent

Start: 2004-12-31End: 2006-08-31Target: 842Updated: 2007-08-23